Burman Laboratories Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 0.50 M
- Company Age 39 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 30.74 Cr
- Revenue Growth -23.43%
- Profit Growth -44.29%
- Ebitda -5.22%
- Net Worth 5.46%
- Total Assets 3.22%
About Burman Laboratories
Burman Laboratories Private Limited (BLPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 March 1985 and has a history of 39 years and ten months. Its registered office is in Shajapur, Madhya Pradesh.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.50 M.
The company has closed loans amounting to ₹30.74 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Robin Goel and Sreedhar Atchutuni serve as directors at the Company.
Company Details
-
LocationShajapur, Madhya Pradesh
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U01100MP1985PTC013512
-
Company No.
013512
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
05 Mar 1985
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Burman Laboratories?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Robin Goel
|
Director | 02-Feb-2024 | Current |
|
Sreedhar Atchutuni
|
Director | 02-Feb-2024 | Current |
Financial Performance of Burman Laboratories.
Burman Laboratories Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 23.43% decrease. The company also saw a substantial fall in profitability, with a 44.29% decrease in profit. The company's net worth moved up by a moderate rise of 5.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Burman Laboratories?
In 2023, Burman Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹307.40 M
Charges Breakdown by Lending Institutions
- Punjab National Bank : 29.22 Cr
- The Hongkong And Shanghai Banking Corporation Limited : 1.52 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Dec 2002 | Punjab National Bank | ₹1.00 Cr | Satisfied |
| 06 Feb 2001 | Punjab National Bank | ₹14.11 Cr | Satisfied |
| 05 Dec 2000 | Punjab National Bank | ₹14.11 Cr | Satisfied |
| 02 Mar 1994 | The Hongkong And Shanghai Banking Corporation Limited | ₹7.60 M | Satisfied |
| 02 Mar 1994 | The Hongkong And Shanghai Banking Corporation Limited | ₹7.60 M | Satisfied |
How Many Employees Work at Burman Laboratories?
Unlock and access historical data on people associated with Burman Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Burman Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Burman Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
